FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.09 EUR | +1.14% |
|
-1.95% | +3.06% |
| Apr. 29 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading | MT |
| Apr. 26 | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies | ZD |
| Sales 2024 * | 19.62B 21.05B | Sales 2025 * | 20.35B 21.83B | Capitalization | 11.34B 12.17B |
|---|---|---|---|---|---|
| Net income 2024 * | 709M 761M | Net income 2025 * | 971M 1.04B | EV / Sales 2024 * | 1.08 x |
| Net Debt 2024 * | 9.85B 10.56B | Net Debt 2025 * | 9.07B 9.73B | EV / Sales 2025 * | 1 x |
| P/E ratio 2024 * |
16
x | P/E ratio 2025 * |
11.8
x | Employees | 119,845 |
| Yield 2024 * |
2.79% | Yield 2025 * |
3.33% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
| 1 day | +0.87% | ||
| 1 week | -2.03% | ||
| Current month | +9.65% | ||
| 1 month | +12.01% | ||
| 3 months | +8.49% | ||
| 6 months | +24.49% | ||
| Current year | +2.98% |
1 week
37.34
40.27
1 month
34.1240.38
Current year
33.8841.62
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 39.12 | +1.22% | 96 570 |
| 24-04-29 | 38.65 | +3.29% | 583,807 |
| 24-04-26 | 37.42 | -0.98% | 435,741 |
| 24-04-25 | 37.79 | -3.00% | 437,031 |
| 24-04-24 | 38.96 | -2.36% | 344,818 |
Delayed Quote Xetra, April 30, 2024 at 05:26 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.65
EUR
Average target price
39.16
EUR
Spread / Average Target
+1.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.98% | 12.15B | |
| -14.58% | 85.02B | |
| +15.05% | 82.37B | |
| +10.49% | 29.29B | |
| -10.17% | 17.21B | |
| -0.32% | 16.7B | |
| -30.88% | 11.8B | |
| +31.86% | 12.12B | |
| -1.63% | 12.13B | |
| -8.00% | 11.67B |
- Stock Market
- Equities
- FME Stock
